Please use this identifier to cite or link to this item:
Title: Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
Authors: Tan, Sharon H. X.
Cook, Alex R.
Heng, Derrick
Ong, Benjamin
Lye, David C.
Tan, Kelvin B.
Keywords: Science::Medicine
Issue Date: 2022
Source: Tan, S. H. X., Cook, A. R., Heng, D., Ong, B., Lye, D. C. & Tan, K. B. (2022). Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age. New England Journal of Medicine, 387(6), 525-532.
Journal: New England Journal of Medicine
Abstract: Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly and replaced the B.1.617.2 (delta) variant as the dominant variant in many countries. Data on the real-world effectiveness of vaccines against the omicron variant in children are lacking.
ISSN: 0028-4793
DOI: 10.1056/NEJMoa2203209
Rights: © 2022 Massachusetts Medical Society. All rights reserved.
Fulltext Permission: none
Fulltext Availability: No Fulltext
Appears in Collections:LKCMedicine Journal Articles

Citations 20

Updated on Feb 3, 2023

Web of ScienceTM
Citations 20

Updated on Feb 6, 2023

Page view(s)

Updated on Feb 6, 2023

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.